Trial of Suvorexant for Sleep in Children With Autism
Phase 2
26
about 4.6 years
13–17
1 site in CA
About this study
Researchers are testing whether suvorexant helps children with autism sleep better. The trial will compare suvorexant to a placebo, using tests like polysomnography and actigraphy to measure sleep patterns. It will last 1664 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take Suvorexant
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
suvorexant
oral (Oral Tablet)
Primary: Change from baseline in sleep architecture as measured by polysomnography (PSG) and/or actigraphy, examples include sleep latency and non-rapid eye movement (NREM)
Secondary: Change from baseline in sleep efficiency as measured by actigraphy
Psychiatry / Mental Health